tiprankstipranks
Advertisement
Advertisement
Fein Lifts Liquidia Price Target to $75 on Reduced Legal Risk and Reinforced Buy Rating
PremiumRatingsFein Lifts Liquidia Price Target to $75 on Reduced Legal Risk and Reinforced Buy Rating
19d ago
Analyst Reiterates Buy on Liquidia as Supreme Court Ruling Enhances Litigation Risk-Reward; $59 Price Target Maintained
Premium
Ratings
Analyst Reiterates Buy on Liquidia as Supreme Court Ruling Enhances Litigation Risk-Reward; $59 Price Target Maintained
20d ago
Liquidia price target raised to $75 from $67 at H.C. Wainwright
Premium
The Fly
Liquidia price target raised to $75 from $67 at H.C. Wainwright
20d ago
Regulatory Hurdles and Competitive Pressures Threaten Liquidia’s YUTREPIA and L606 Prospects
PremiumCompany AnnouncementsRegulatory Hurdles and Competitive Pressures Threaten Liquidia’s YUTREPIA and L606 Prospects
1M ago
Liquidia Technologies Rides YUTREPIA Surge in Earnings Call
Premium
Company Announcements
Liquidia Technologies Rides YUTREPIA Surge in Earnings Call
1M ago
Liquidia price target raised to $60 from $57 at Jefferies
Premium
The Fly
Liquidia price target raised to $60 from $57 at Jefferies
1M ago
Constructive Buy Thesis on Liquidia Driven by Pulmonary Hypertension Opportunity and Upcoming Value Catalysts
PremiumRatingsConstructive Buy Thesis on Liquidia Driven by Pulmonary Hypertension Opportunity and Upcoming Value Catalysts
2M ago
Insmed price target lowered to $175 from $208 at Wells Fargo
Premium
The Fly
Insmed price target lowered to $175 from $208 at Wells Fargo
3M ago
Liquidia price target raised to $51 from $44 at Wells Fargo
Premium
The Fly
Liquidia price target raised to $51 from $44 at Wells Fargo
3M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100